newsfilter
← Latest News
GlobeNewswire·

Belite Bio Announces Uplisting to the Nasdaq Global Select Market

SAN DIEGO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting